Alterity Therapeutics (ATHE.Q) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company’s patent application No.17/239,375. “As the scientific…
Pharmaceuticals
BioVaxys Technology (BIOV.C) announced today that Immunologist Yvelise Barrios, MD, PhD, has joined the Company as a Scientific Adviser to support development of CoviDTH. Furthermore, studies conducted by Dr….
Medexus Pharmaceuticals (MDP.T) announced today that medac GmbH, the Company’s licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response…
Ardelyx (ARDX.Q) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s New Drug Application (NDA) for…
ERYTECH Pharma (ERYP.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track designation for the treatment of acute lymphocytic leukemia (ALL) patients who…
Cocrystal Pharma (COCP.Q) announced today that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2 Delta and Gamma variants. “These in vitro SARS-CoV-2…
Filament Health (FH.NEO) announced today that it has been granted an amendment to its existing Health Canada Dealer’s License, bolstering the Company’s position at the forefront of natural psychedelic…
PharmaDrug (BUZZ.C) passed their potential cancer fighter, cepharanthine02HC1, the active ingredient in their oral drug PD-001, through preclinicals today. The results of the test are good. It’s proven…
Lexaria Bioscience (LEXX.Q) announced today that its DehydraTECH™ technology has been embraced by consumer brands and is now available for sale in over 7,000 stores across the US. “Lexaria’s…
Back in January of this year, we told you about a psychedelics company that was going to come at that sector like many had talked about, but few had…